DK452587A - APPLICATION OF A MONOCLONAL ANTIBODY OR NON-FC FRAGMENT THEREOF OR A LIGAND FOR THERAPY OF TUMORS - Google Patents

APPLICATION OF A MONOCLONAL ANTIBODY OR NON-FC FRAGMENT THEREOF OR A LIGAND FOR THERAPY OF TUMORS

Info

Publication number
DK452587A
DK452587A DK452587A DK452587A DK452587A DK 452587 A DK452587 A DK 452587A DK 452587 A DK452587 A DK 452587A DK 452587 A DK452587 A DK 452587A DK 452587 A DK452587 A DK 452587A
Authority
DK
Denmark
Prior art keywords
growth factor
therapy
monoclonal antibody
factor
ligand
Prior art date
Application number
DK452587A
Other languages
Danish (da)
Other versions
DK452587D0 (en
Inventor
Klaus Bosslet
Hans Ulrich Schorlemmer
Hans Harald Sedlacek
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK452587D0 publication Critical patent/DK452587D0/en
Publication of DK452587A publication Critical patent/DK452587A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/303—Liver or Pancreas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

The use of a monoclonal antibody, of one of its non-Fc fragments or another ligand, which have the properties of blocking the pinocytosis of colloidal gold, the production of superoxide anions or the release of enzymes, particularly of neutral proteases, very particularly collagenase or elastase, of growth factors, epidermal growth factor, platelet-derived growth factor, colony-stimulating factor, erythropoietin, fibroblast growth factor, tumour angiogenesis factor or transforming growth factor from pancreatic tumour cells, for the therapy of tumours is described.
DK452587A 1986-08-30 1987-08-28 APPLICATION OF A MONOCLONAL ANTIBODY OR NON-FC FRAGMENT THEREOF OR A LIGAND FOR THERAPY OF TUMORS DK452587A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863629640 DE3629640A1 (en) 1986-08-30 1986-08-30 USE OF MONOCLONAL ANTIBODIES FOR THE TREATMENT OF TUMORS

Publications (2)

Publication Number Publication Date
DK452587D0 DK452587D0 (en) 1987-08-28
DK452587A true DK452587A (en) 1988-03-01

Family

ID=6308615

Family Applications (1)

Application Number Title Priority Date Filing Date
DK452587A DK452587A (en) 1986-08-30 1987-08-28 APPLICATION OF A MONOCLONAL ANTIBODY OR NON-FC FRAGMENT THEREOF OR A LIGAND FOR THERAPY OF TUMORS

Country Status (9)

Country Link
EP (1) EP0258817B1 (en)
JP (1) JP2624968B2 (en)
KR (1) KR880002543A (en)
AT (1) ATE104679T1 (en)
AU (1) AU594496B2 (en)
DE (2) DE3629640A1 (en)
DK (1) DK452587A (en)
PT (1) PT85599B (en)
ZA (1) ZA876438B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9106678D0 (en) * 1991-03-28 1991-05-15 Ferguson Mark W J Wound healing
US7507705B2 (en) 1997-10-02 2009-03-24 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3329184A1 (en) * 1983-08-12 1985-02-21 Behringwerke Ag, 3550 Marburg MONOCLONAL ANTIBODIES WITH SPECIFICITY FOR MEMBRANE-ASSOCIATED ANTIGENS
DE3531301A1 (en) * 1985-09-02 1987-03-05 Behringwerke Ag MONOCLONAL ANTIBODIES AGAINST TUMOR ASSOCIATED GLYCOPROTEINS, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DE3416774A1 (en) * 1984-05-07 1985-11-14 Behringwerke Ag, 3550 Marburg MONOCLONAL ANTIBODIES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
CA1339798C (en) * 1985-02-01 1998-04-07 Alan N. Houghton Method for treatment of neuroectodermal malignancies and epithelial carcinomas in humans

Also Published As

Publication number Publication date
ZA876438B (en) 1988-04-27
EP0258817A3 (en) 1988-06-15
JPS6372630A (en) 1988-04-02
AU7766387A (en) 1988-03-03
PT85599A (en) 1987-09-01
EP0258817A2 (en) 1988-03-09
DK452587D0 (en) 1987-08-28
AU594496B2 (en) 1990-03-08
KR880002543A (en) 1988-05-09
EP0258817B1 (en) 1994-04-20
JP2624968B2 (en) 1997-06-25
DE3789643D1 (en) 1994-05-26
ATE104679T1 (en) 1994-05-15
DE3629640A1 (en) 1988-03-03
PT85599B (en) 1990-05-31

Similar Documents

Publication Publication Date Title
DK1349870T3 (en) Compositions for the therapy and diagnosis of ovarian cancer
WO2000036107A3 (en) Compositions and methods for therapy and diagnosis of ovarian cancer
FR2435989A1 (en) ADDED CUTTING TOOL PAD
IL84285A0 (en) Polynucleotide molecule,chimeric antibody with specificity to human tumor antigen,process for the preparation thereof and methods utilizing the same
DE122008000039I1 (en) Modular Assembly of Antibody Genes, Antibodies Produced, and Their Applications.
NO963589L (en) Description of cancer states by MAGE gene expression
DE69133472D1 (en) Antibodies and their therapeutic use
NO20001977L (en) Compositions and Methods for Treating Primary and Metastatic Neoplastic Diseases Using Õ Arsenic Compounds
EP1468014A4 (en) Compositions and methods for wt1 specific immunotherapy
DE68918217T2 (en) Family of modified antibodies with high affinity for the treatment of cancer.
DE69535002D1 (en) RECOMBINANT HUMANIZED ANTIBODIES AGAINST FB5
DK452587A (en) APPLICATION OF A MONOCLONAL ANTIBODY OR NON-FC FRAGMENT THEREOF OR A LIGAND FOR THERAPY OF TUMORS
DE3852561D1 (en) Monoclonal antibodies, hybridomas, their production and their use.
AU627084B2 (en) A novel tumor associated antigen
ATE122723T1 (en) RETINOBLASTOMA GENE PRODUCT ANTIBODIES AND USES THEREOF.
ATE95069T1 (en) TARGETING OF DIFFERENTIATION INDUCTORS TO TUMOR CELLS BY ANTIBODIES AND LIGANDS.
DE3766788D1 (en) MOLYBDAEN-ALKALI-METAL-AETHYLENE GLYCOL COMPLEXES, USED AS EPOXYDATION CATALYSTS AND THEIR PRODUCTION PROCESS.
EP0185135A3 (en) Novel monoclonal antibody
AU5752490A (en) A novel tumor associated antigen
DE3786695T2 (en) Tumor Associated Antigen.
FI892197A (en) FOERFARANDE FOER DETEKTERING AV TUMOERER.
ATE88641T1 (en) MOLECULES WITH BINDING SITE OF ANTIBODIES POSSESSING CATALYTIC PROPERTIES.
DE3177155D1 (en) USE OF 2-BETA-D-RIBOFURANOSYLTHIAZOL-4-CARBOXAMIDES FOR THE PRODUCTION OF MEDICATIONS FOR THE TREATMENT OF CANCER TUMORS.
CA928861A (en) Evanescent wave coupling technique for beam shaping
NO158111C (en) PROCEDURE FOR THE ASSEMBLY OF CONSTRUCTION PARTS, SPECIFICALLY FOR THE MOBILE INDUSTRY.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment